Vaccination against bluetongue safety and immune response in the field;Impfung gegen die Blauzungenkrankheit: Verträglichkeit und Immunantwort in der Praxis

Schweizer Archiv fur Tierheilkunde

Volumn 151, Issue 3, 2009, Pages 101-108

  Bruckner, L ^a   Fricker, R ^a   Hug, M ^b   Hotz, R ^b   Muntwyler, J ^c   Iten, C ^c   Griot, C ^a  

^a INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (Switzerland)

^b Novartis Centre de Recherche Santé Animale CRA   (France)

^c Beratungs und Gesundheitsdienst Kleinwiederkäuer ^*  (Switzerland)

Author keywords

Animal disease; Bluetongue disease; Field trial; Vaccination

Indexed keywords

VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BLUETONGUE ORBIVIRUS; CATTLE; CATTLE DISEASE; FEMALE; GOAT; GOAT DISEASE; HYPOPITUITARISM; IMMUNOLOGY; MALE; SHEEP DISEASE; SWITZERLAND; TREATMENT OUTCOME; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; BLUETONGUE; BLUETONGUE VIRUS; CATTLE; CATTLE DISEASES; FEMALE; GOAT DISEASES; GOATS; HYPOPITUITARISM; MALE; SWITZERLAND; TREATMENT OUTCOME; VACCINATION; VIRAL VACCINES;

ANIMALIA; BLUETONGUE VIRUS; BLUETONGUE VIRUS 8; BOS; CAPRA HIRCUS; OVIS ARIES;

EID: 63449104921     PISSN: 00367281     EISSN: None     Source Type: Journal    
DOI: 10.1024/0036-7281.151.3.101     Document Type: Article

References (39)

1. Anonymous: Possible use of vaccination against bluetongue in Europe. Scientific Committee on Animal Health and Animal Welfare, European Commission, 2000.
2. Anonymous: Vaccination considered the only practical safeguard against bluetongue. Vet. Rec. 2008a, 162:194.
3. Anonymous: Bluetongue spreads despite vaccinations. New Scientist 2008b, 25. Juli.
4. Baldet T., Delécolle J.C., Cètre-Sossah C., Mathieu B., Meiswinkel R., Gerbier G.: Indoor activity of Culicoides associated with live stock in the bluetongue virus (BTV) affected region of northern France during autumn 2006. Prev. Vet. Med. 2008, 87: 84-97.
5. Batten CA., Maan S., Shaw AE., Maan NS., Mertens PP.: A European field strain of bluetongue virus derived from two parental vaccine strains by genome segment reassortment. Virus Res. 2008, 137:56-63.
6. Boone J.D., Balasuriya U.B., Karaca K., Audonnet J.C., Yao J., He L., Nordgren R., Monaco F., Savini G., Gardner I.A., Machlachlan N.J.: Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep. Vaccine 2007, 25: 672-678.
7. Cagienard A., Dall'Acqua F., Thür B., Mellor P.S., Denison E., Griot C., Stärk K.D.C.: Bluetongue surveillance in Switzerland in 2003. Vet. Ital. 2004,40: 133-136.
8. Conraths F.J., Kramer M., Freuling C., Hoffmann B., Stauhach C., Gethmann J., Teifke J., Mettenleiter T.C., Beer M.: Blauzungenkrankheit in Deutschland: Klinik, Diagnostik und Epidemiologie. Prakt. Tierarzt 2007,88: 9-15.
9. Darpel K.E., Batten C.A., Veronesi E., Shaw A.E., Anthony S., Bachanek-Bankowska K., Kgosana L., Bin-Tarif A., Carpenter S., Müller-Doblies U. U., Takamatsu H.H., Mellor P.S., Mertens P.P., Oura C.A.: Clinical signs and pathology shown by British sheep and cattle infected with bluetongue virus serotype 8 derived from the 2006 outbreak in northern Europe. Vet. Rec. 2007,161: 253-261.
10. De Clercq K., De Leeuw I., Verheyden B., Vandemeulebroucke E., Vanbinst T., et al.: Transplacental infection and apparently immunotolerance induced by a wild-type bluetongue virus serotype 8 natural infection. Transbound. Emerg. Dis. 2008, 55: 352-359.
11. Elbers A.R.W., BackxA., Meroc E., Gerbier G., Staubach C., Hendrickx G., Van der Spek A., Mintiens K.: Field observations during the bluetongue serotype 8 epidemic in 2006 I. Detection of first outbreaks and clinical signs in sheep and cattle in Belgium, France and the Netherlands. Prev. Vet. Med. 2008,87: 21-30.
12. Enserink M.: Animal disease. Exotic disease of farm animals tests Europe's responses. Science 2008, 319: 710-711.
13. Erasmus B.J.: The control of bluetongue in an enzootic situation. Aust. Vet. J. 1975, 51: 209-210.
14. Heinrich M., Reinacher M., Hamann HP.: Lethal bluetongue virus infection in an alpaca. Vet. Rec. 2007, 161: 764.
15. Hofmann M., Griot C., Chaignat V., Perler L., Thür B.: Blauzungenkrankheit erreicht die Schweiz. Schweiz. Arch. Tierheilk. 2008, 150:49-56.
16. Goldarazena A., Romón P., Aduriz G., Balenghien T., Baldet T., Delécolle J.C.: First record of Culicoides imicola, the main vector of bluetongue virus in Europe, in the Basque Country (northern Spain). Vet. Rec. 2008, 162: 820-821.
17. lben B.: Blauzungenkrankheit jetzt auch in Deutschland. Grosstierpraxis 2006, 7: 418-427.
18. Jauniaux T.P., De Clercq K.E., Cassart D.E., Kennedy S., Vandenbussche F.E., Vandemeulebroucke E.L., et al.: Bluetongue in Eurasian Lynx. Emerg. Infect. Dis. 2008, 14:1496-1497.
19. Linden A., Mousset B., Grégoire F., Hanrez D., Vandenbussche F., Vandemeulebroucke E., Vanbinst T., Verheyden B., De Clerck, K.: Bluetongue virus antibodies in wild red deer in southern Belgium. Vet. Rec. 2008, 162: 459.
20. Lobato Z.I., Coupar B.E., Gray C.P., Lunt R., Andrew M.E.: Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens. Vet. Immunol. Immunopathol. 1997, 59: 293-309.
21. Mackay DX: Authorisation within the European Union of vaccines against antigenically variable viruses responsible for major epizootic diseases. Rev. Sci. Tech. 2007, 26: 421-428.
22. MacLachlan N.J., Crafford I.E., Vernau W., Gardner I.A., Goddard A., Guthrie A.J., Venter E.H.: Experimental reproduction of severe bluetongue in sheep. Vet. Pathol. 2008, 45: 310-315.
23. Meiswinkel R., Baldet T., de Deken R., Takken W., Delécoiμle J.C., Mellar P.S.: The 2006 outbreak of bluetongue in northern Europe -The entomological perspective. Prev. Vet. Med. 2008, 87: 55-63.
24. Mellor P.S., Carpenter S., Harrup L., Baylis M., Mertens P.P.C.: Bluetongue in Europe and the mediterranean basin: history of occurrence prior to 2006. Prev. Vet. Med. 2008, 87: 4-20.
25. Mertens P., Baylis M., Mellor P.: Bluetongue 1. Hrsg. Elsevier Ltd., United Kingdom, 2008.
26. Mintiens K., Méroc E., Faes C., Abrahantes J.C., Hendrickx G., Staubach C., Gerbier G., Elbers A.R., Aerts M., De Clercq K.: Impact of human interventions on the spread of bluetongue virus serotype 8 during the 2006 epidemic in north-western Europe. Prev. Vet. Med. 2008, 87: 145-161.
27. Monaco F., Camma C., Serini S., Savini G.: Differentiation between field and vaccine strain of bluetongue virus serotype 16. Vet. Microbiol. 2006, 116: 45-52.
28. Patta C., Giovannini A., Rolesu S., Nannini D., Savini G., Calistri P., et al. Bluetongue vaccination in Europe: the Italian experience. Vet. Ital. 2004, 40: 601-610.
29. Perrin A., Albina E., Bréard E., Sailleau C., Promé S., Grillet C., Kwiatek O., Russo P., Thiéry R., Zientara S., Cêtre-Sossah C.: Recombinant capripoxviruses expressing proteins of bluetongue virus: evaluation of immune responses and protection in small ruminants. Vaccine 2007, 25: 6774-6783.
30. ProMED-mail: Bluetongue - Europe (68): BTV-8, BTV-1, France, 2008, 27 Oct.
31. Saegerman C., Hubaux M., Urbain B., Lengelé L., Berkvens D.: Regulatory issues surrounding the temporary authorisation of animal vaccination in emergency situations: the example of bluetongue in Europe. Rev. Sci. Tech. 2007, 26: 395-413.
32. Savini G., Ronchi GF., Leone A., Ciarelli A., Migliaccio P., Franchi P., Mercante MT., Fini A.: An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy. Vet. Microbiol. 2007, 124: 140-146.
33. Savini G., MacLachlan N.J., Sanchez-Vizcaino J.M., Zientara S.: Vaccines against bluetongue in Europe. Comp. Immunol. Microbiol. Infect. Dis. 2008a, 31: 101-120.
34. Savini G., Hamers C., Conte A., Migliaccio P., Bonfini B., Teodori L., Di Ventura M., Hudelet P., Schumacher C., Caporale V.: Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle. Vet. Microbiol. 2008b, in press.
35. Schwartz-Cornil I., Mertens P.P.C., Contreras V., Hemati B., Pascale F., Bréard E., Mellor P.S., MacLachlan N.J., Zientara S.: Bluetongue virus: virology, pathogenesis and immunity. Vet. Res. 2008, 39:46.
36. Van Dijk A.A.: Development of recombinant vaccines against bluetongue. Biotechnol. Adv. 1993, 11: 1-12.
37. Vercauteren G., Miry C., Vandenbussche F., Ducatelle R., Van der Heyden S., Vandemeulebroucke E., De Leeuw I., Deprez P., Chiers Kl, De Clercq K.: Bluetongue virus serotype 8-associated congenital hydranencephaly in calves. Transbound. Emerg. Dis. 2008, 55: 293-298.
38. Verwoerd D., Erasmus B.J.: Bluetongue. In: Infectious diseases of livestock. Hrsg. J.A. Coetzer und R.C. Tustin R.C. 2.. Ausgabe. Oxford University Press, Cape Town, 2004, 1201-1220.
39. Worwa G., Thür B., Griot C., Hofmann M., MacLachlan J.N., Chaignat V.: Blauzungenkrankheit bei Schweizer Schafrassen: Klinische Symptome nach experimenteller Infektion mit dem BTV-Serotyp 8. Schweiz. Arch. Tierheilk. 2008, 150: 491-198.